Press Releases


CollabRx, Sengenics Partner on Cancer Diagnostics

CollabRx today announced a deal with Sengenics to incorporate each other’s products into molecular diagnostics tests and reports aimed at cancer.   Under the terms of the agreement, Sengenics will integrate CollabRx’s interpretive content resources into its cancer exome sequencing


Read More »

FEATURED PRODUCTS

IMMUNOME™

High-throughput platform of 1600+
immunomodulatory proteins

CTA array

High-throughput protein array of
200+ cancer-testis antigens

Custom array

Flexible miniaturised format for
high-throughput screening

X